the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
Published 3 months ago • 70 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:02
rwd from insight-mm: duration of therapy and treatment sequencing
-
3:18
combining ogm with targeted ngs to improve the diagnosis and prognostication of mds
-
1:33
prognostic impact of wt1 mutations in newly diagnosed and r/r aml
-
3:33
the value of wgs and whole transcriptome sequencing in the diagnosis of hematological malignancies
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:39
shallow wgs vs conventional cytogenetic analysis for diagnosing and stratifying mds
-
8:13
treatment strategies for high-risk mm
-
7:45
early trial of sonrotoclax to treat chronic lymphocytic leukemia (cll) - ash 2023 dr. mazyar shadman
-
7:09
beigene patient perspective: living with waldenström’s macroglobulinemia
-
8:18
mechanisms of action of ibrutinib, ruxolitinib, and belumosudil, and their role in cgvhd treatment
-
4:22
management of acute gvhd
-
1:23
management of high-risk newly diagnosed mm
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
1:12
the safety and efficacy of mb-106 for the treatment of waldenström’s macroglobulinemia
-
1:28
improving the management of gvhd
-
1:18
results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
-
1:30
the prognostic value of patient-reported outcomes in mds
-
1:47
shared treatment decision-making
-
0:58
management strategies for acute and chronic gvhd following allosct
-
1:58
can wgs and rnaseq replace conventional first-line diagnostics for acute leukemia?
-
3:50
advances in the prevention and treatment of gvhd